| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | NUP98 POM121L2 NUP62 NUP214 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 2.28e-16 | 25 | 127 | 10 | GO:0017056 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 4.30e-12 | 27 | 127 | 8 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 1.09e-09 | 51 | 127 | 8 | GO:0005048 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 SOX9 SP3 ZNF609 BCAS3 NUP98 NUP62 CIC NFATC2 NFE2L1 NFIX MCM3AP MLLT6 NUP153 BAHCC1 | 7.23e-05 | 739 | 127 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 SOX9 SP3 BCAS3 TACC2 RUNX1T1 TFDP1 ARNT NFATC2 HEY1 NR3C2 BCL10 DOT1L HTT PROX1 | 8.91e-05 | 753 | 127 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | heat shock protein binding | 6.18e-04 | 163 | 127 | 6 | GO:0031072 | |
| GeneOntologyBiologicalProcess | RNA transport | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 1.89e-14 | 175 | 130 | 16 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 1.89e-14 | 175 | 130 | 16 | GO:0050657 |
| GeneOntologyBiologicalProcess | mRNA transport | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 2.05e-14 | 145 | 130 | 15 | GO:0051028 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 2.47e-14 | 178 | 130 | 16 | GO:0051236 |
| GeneOntologyBiologicalProcess | RNA localization | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 5.46e-13 | 217 | 130 | 16 | GO:0006403 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 POM121B NUP153 HTT | 4.49e-12 | 249 | 130 | 16 | GO:0015931 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | NUP98 POM121L2 NUP62 NUP214 POM121C POM121 MCM3AP NXF3 POM121B NUP153 | 4.97e-10 | 96 | 130 | 10 | GO:0006405 |
| GeneOntologyBiologicalProcess | nuclear pore organization | 9.74e-10 | 18 | 130 | 6 | GO:0006999 | |
| GeneOntologyBiologicalProcess | nuclear transport | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 LZTS2 POM121B NUP153 | 2.15e-09 | 378 | 130 | 16 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 NXF3 LZTS2 POM121B NUP153 | 2.15e-09 | 378 | 130 | 16 | GO:0006913 |
| GeneOntologyBiologicalProcess | nuclear export | NUP98 POM121L2 NUP62 NUP214 NUP42 POM121C POM121 MCM3AP NXF3 LZTS2 POM121B NUP153 | 2.17e-09 | 185 | 130 | 12 | GO:0051168 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | SOX9 NUP50 NUP98 POM121L2 NUP62 NUP214 NUP58 POM121C NUP54 POM121 LZTS2 POM121B EIF2AK3 NUP153 HTT | 9.41e-09 | 362 | 130 | 15 | GO:0034504 |
| GeneOntologyBiologicalProcess | protein import into nucleus | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 4.44e-08 | 195 | 130 | 11 | GO:0006606 |
| GeneOntologyBiologicalProcess | import into nucleus | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP58 POM121C NUP54 POM121 POM121B NUP153 | 6.05e-08 | 201 | 130 | 11 | GO:0051170 |
| GeneOntologyBiologicalProcess | intracellular transport | NUP50 SYNRG NUP98 MPDZ POM121L2 TACC2 NUP62 NUP214 NUP42 NUP58 AP3B1 POM121C DNAJC6 PREPL NUP54 EPS15L1 POM121 TRAPPC12 MCM3AP NUP210 NXF3 TMEM108 LZTS2 POM121B NUP153 HTT | 1.88e-06 | 1496 | 130 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | protein localization to organelle | SOX9 NUP50 NUP98 POM121L2 NUP62 NUP214 NUP58 AP3B1 POM121C NUP54 POM121 TRAPPC12 TMEM108 FAM149B1 LZTS2 POM121B EIF2AK3 NUP153 HTT | 5.39e-05 | 1091 | 130 | 19 | GO:0033365 |
| GeneOntologyBiologicalProcess | intracellular protein transport | NUP50 SYNRG NUP98 MPDZ POM121L2 NUP62 NUP214 NUP42 NUP58 AP3B1 POM121C NUP54 POM121 POM121B NUP153 | 6.70e-05 | 740 | 130 | 15 | GO:0006886 |
| GeneOntologyBiologicalProcess | nucleus organization | 1.03e-04 | 170 | 130 | 7 | GO:0006997 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP58 AP3B1 POM121C NUP54 POM121 POM121B NUP153 | 1.03e-04 | 515 | 130 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | glial cell fate commitment | 2.20e-04 | 19 | 130 | 3 | GO:0021781 | |
| GeneOntologyCellularComponent | nuclear pore | NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 POM121B NUP153 | 1.84e-15 | 101 | 129 | 14 | GO:0005643 |
| GeneOntologyCellularComponent | nuclear membrane | NUP50 PAK5 NUP98 NUP62 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 DNAJB2 POM121B NUP153 | 3.48e-08 | 349 | 129 | 14 | GO:0031965 |
| GeneOntologyCellularComponent | nuclear envelope | NUP50 PAK5 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 MCM3AP NUP210 DNAJB2 POM121B NUP153 | 3.71e-07 | 560 | 129 | 16 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FOXO3 NUP50 NUP98 POM121L2 NUP62 NUP214 NUP42 NUP58 POM121C TFDP1 NUP54 ARNT POM121 NFATC2 MCM3AP NUP210 NXF3 ANAPC16 POM121B NUP153 NPAS2 | 1.04e-04 | 1377 | 129 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.75e-04 | 18 | 129 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | clathrin coat | 3.97e-04 | 56 | 129 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | postsynaptic density | MPDZ CSMD2 DNAJC6 PDLIM5 SNAP91 CPEB4 SYN2 TMEM108 NR3C2 CAP2 | 4.95e-04 | 451 | 129 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | Golgi lumen | 5.79e-04 | 109 | 129 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | asymmetric synapse | MPDZ CSMD2 DNAJC6 PDLIM5 SNAP91 CPEB4 SYN2 TMEM108 NR3C2 CAP2 | 7.62e-04 | 477 | 129 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | nuclear pore central transport channel | 7.78e-04 | 7 | 129 | 2 | GO:0044613 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic endocytic zone membrane | 7.78e-04 | 7 | 129 | 2 | GO:0098894 | |
| GeneOntologyCellularComponent | microtubule minus-end | 7.78e-04 | 7 | 129 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 9.09e-04 | 31 | 129 | 3 | GO:0030131 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MPDZ CSMD2 DNAJC6 PDLIM5 SNAP91 CPEB4 SYN2 TMEM108 NR3C2 CAP2 | 1.14e-03 | 503 | 129 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MPDZ CSMD2 DNAJC6 PDLIM5 SNAP91 CPEB4 SYN2 TMEM108 NR3C2 CAP2 | 1.52e-03 | 523 | 129 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | inclusion body | 2.35e-03 | 90 | 129 | 4 | GO:0016234 | |
| HumanPheno | Digenic inheritance | 7.45e-06 | 16 | 43 | 4 | HP:0010984 | |
| HumanPheno | Hyperactive renin-angiotensin system | 3.05e-05 | 8 | 43 | 3 | HP:0000841 | |
| Domain | Cl_channel-K | 4.30e-05 | 2 | 123 | 2 | IPR002250 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 8.99e-18 | 40 | 89 | 12 | MM14945 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.27e-17 | 41 | 89 | 12 | MM15200 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.76e-17 | 42 | 89 | 12 | MM15039 |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 2.43e-17 | 43 | 89 | 12 | MM14609 |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 3.88e-17 | 32 | 89 | 11 | M29579 |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 5.80e-17 | 33 | 89 | 11 | M27016 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 8.12e-17 | 47 | 89 | 12 | MM14939 |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 8.52e-17 | 34 | 89 | 11 | M27041 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.24e-16 | 35 | 89 | 11 | M27320 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.42e-16 | 49 | 89 | 12 | MM14837 |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.77e-16 | 36 | 89 | 11 | M26974 |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.77e-16 | 36 | 89 | 11 | M27245 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.86e-16 | 50 | 89 | 12 | MM14610 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 2.42e-16 | 51 | 89 | 12 | MM15151 |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.51e-16 | 37 | 89 | 11 | M1029 |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.51e-16 | 37 | 89 | 11 | M27038 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 4.87e-16 | 39 | 89 | 11 | M27238 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 6.55e-16 | 55 | 89 | 12 | MM14917 |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 9.08e-16 | 41 | 89 | 11 | M29574 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.31e-15 | 58 | 89 | 12 | MM15149 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.31e-15 | 58 | 89 | 12 | MM14736 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.64e-15 | 43 | 89 | 11 | M26975 |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.17e-15 | 44 | 89 | 11 | M109 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 3.74e-15 | 46 | 89 | 11 | M27397 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 4.44e-15 | 84 | 89 | 13 | MM14929 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 4.86e-15 | 47 | 89 | 11 | M27395 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 5.71e-15 | 65 | 89 | 12 | MM15147 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 RPTOR NUP210 POM121B NUP153 | 1.52e-14 | 92 | 89 | 13 | MM14951 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.06e-14 | 53 | 89 | 11 | M27212 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 2.50e-14 | 73 | 89 | 12 | MM14948 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.58e-14 | 54 | 89 | 11 | M29594 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 NUP210 NUP153 | 4.90e-14 | 77 | 89 | 12 | M27226 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C TNFRSF21 NUP54 POM121 RPTOR NUP210 NUP153 | 5.31e-14 | 101 | 89 | 13 | M27253 |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 7.34e-14 | 59 | 89 | 11 | M27606 |
| Pathway | REACTOME_GLUCOSE_METABOLISM | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.08e-13 | 82 | 89 | 12 | MM15394 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C TNFRSF21 NUP54 POM121 NUP210 NUP153 | 1.08e-13 | 82 | 89 | 12 | M27250 |
| Pathway | REACTOME_SUMOYLATION | NUP50 SP3 NUP98 NUP62 NUP214 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 NUP210 NR3C2 POM121B NUP153 | 1.44e-13 | 169 | 89 | 15 | MM14919 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.95e-13 | 86 | 89 | 12 | MM15413 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 6.32e-13 | 71 | 89 | 11 | M27394 |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.02e-12 | 74 | 89 | 11 | M48006 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 4.29e-12 | 84 | 89 | 11 | M725 |
| Pathway | REACTOME_GLUCOSE_METABOLISM | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 4.90e-12 | 85 | 89 | 11 | M1870 |
| Pathway | REACTOME_MITOTIC_PROPHASE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 6.11e-12 | 114 | 89 | 12 | MM15361 |
| Pathway | REACTOME_SUMOYLATION | NUP50 SP3 NUP98 NUP62 NUP214 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 NUP210 NR3C2 NUP153 | 1.19e-11 | 189 | 89 | 14 | M27214 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.70e-11 | 99 | 89 | 11 | M27474 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 5.74e-11 | 106 | 89 | 11 | M27458 |
| Pathway | REACTOME_TRNA_PROCESSING | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 9.52e-11 | 111 | 89 | 11 | M27684 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.54e-10 | 116 | 89 | 11 | M29806 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 3.79e-10 | 126 | 89 | 11 | M45009 |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 5.76e-10 | 131 | 89 | 11 | M5283 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.01e-09 | 138 | 89 | 11 | M29805 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.09e-09 | 139 | 89 | 11 | M715 |
| Pathway | REACTOME_MITOTIC_PROPHASE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.37e-09 | 142 | 89 | 11 | M27660 |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 ACAN NUP210 HS3ST3B1 POM121B NUP153 | 1.42e-09 | 271 | 89 | 14 | MM15406 |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NUP54 POM121 NUP210 NUP153 | 1.53e-09 | 109 | 89 | 10 | M39542 |
| Pathway | REACTOME_HIV_LIFE_CYCLE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.29e-09 | 149 | 89 | 11 | M4076 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.63e-09 | 151 | 89 | 11 | M550 |
| Pathway | REACTOME_INFLUENZA_INFECTION | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 3.98e-09 | 157 | 89 | 11 | M4669 |
| Pathway | REACTOME_HCMV_INFECTION | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 5.54e-09 | 162 | 89 | 11 | M29804 |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.40e-08 | 177 | 89 | 11 | M27476 |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 2.81e-08 | 30 | 89 | 6 | M47752 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 ACAN NUP210 HS3ST3B1 NUP153 | 2.89e-08 | 288 | 89 | 13 | M16864 |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 6.07e-08 | 204 | 89 | 11 | M45011 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 ARNT POM121 RPTOR NUP210 ANAPC16 NR3C2 POM121B NUP153 | 9.15e-08 | 505 | 89 | 16 | MM15548 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.61e-07 | 277 | 89 | 12 | MM15414 |
| Pathway | REACTOME_HIV_INFECTION | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.14e-07 | 231 | 89 | 11 | M12469 |
| Pathway | BIOCARTA_NPC_PATHWAY | 4.74e-07 | 11 | 89 | 4 | M22033 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 6.48e-07 | 27 | 89 | 5 | M29807 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C TNFRSF21 TFDP1 NUP54 ARNT POM121 RPTOR NUP210 ANAPC16 NR3C2 EIF2AK3 NUP153 NPAS2 | 7.54e-07 | 828 | 89 | 19 | M27827 |
| Pathway | REACTOME_M_PHASE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 ANAPC16 POM121B NUP153 | 8.74e-07 | 387 | 89 | 13 | MM15364 |
| Pathway | REACTOME_INTERFERON_SIGNALING | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.13e-06 | 273 | 89 | 11 | M983 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.60e-06 | 283 | 89 | 11 | M13087 |
| Pathway | REACTOME_SARS_COV_2_INFECTION | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 2.73e-06 | 299 | 89 | 11 | M41727 |
| Pathway | REACTOME_CELL_CYCLE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CDC14A TFDP1 NUP54 POM121 NUP210 ANAPC16 POM121B NUP153 | 4.99e-06 | 603 | 89 | 15 | MM14635 |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CDC14A TFDP1 NUP54 POM121 NUP210 ANAPC16 NUP153 | 1.04e-05 | 561 | 89 | 14 | M5336 |
| Pathway | REACTOME_M_PHASE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 ANAPC16 NUP153 | 1.16e-05 | 417 | 89 | 12 | M27662 |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.43e-05 | 24 | 89 | 4 | MM15658 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO3 SOX9 NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C TFDP1 NUP54 ARNT POM121 RPTOR NUP210 NR3C2 POM121B NUP153 | 5.80e-05 | 1022 | 89 | 18 | MM15436 |
| Pathway | REACTOME_CELL_CYCLE | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CDC14A TFDP1 NUP54 POM121 NUP210 ANAPC16 NUP153 | 1.07e-04 | 694 | 89 | 14 | M543 |
| Pathway | REACTOME_METABOLISM_OF_RNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C ADARB1 NUP54 POM121 NUP210 POM121B NUP153 | 1.16e-04 | 612 | 89 | 13 | MM15547 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.16e-04 | 76 | 89 | 5 | M27215 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.28e-04 | 16 | 89 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.55e-04 | 17 | 89 | 3 | M27412 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 1.79e-04 | 471 | 89 | 11 | M39009 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | NUP50 SP3 NUP98 MUC19 MUC16 NUP62 NUP214 XPNPEP2 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 SPON2 NUP210 NR3C2 BCL10 POM121B NUP153 | 3.36e-04 | 1389 | 89 | 20 | MM15307 |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.93e-04 | 23 | 89 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.69e-04 | 26 | 89 | 3 | M27483 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | NUP50 SP3 NUP98 MUC16 NUP62 NUP214 MUC12 XPNPEP2 NUP42 NUP58 NSMCE2 POM121C NUP54 POM121 SPON2 NUP210 NR3C2 BCL10 MUC3A NUP153 | 7.30e-04 | 1475 | 89 | 20 | M19806 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.88e-04 | 68 | 89 | 4 | M27303 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 8.88e-04 | 68 | 89 | 4 | MM14921 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.91e-03 | 140 | 89 | 5 | M27484 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C ADARB1 NUP54 POM121 NUP210 NUP153 | 1.92e-03 | 724 | 89 | 12 | M16843 |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.04e-03 | 142 | 89 | 5 | MM15499 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.10e-03 | 143 | 89 | 5 | M27275 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.23e-03 | 145 | 89 | 5 | M27753 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.54e-03 | 99 | 89 | 4 | MM14910 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.78e-03 | 236 | 89 | 6 | M27185 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.85e-03 | 50 | 89 | 3 | M48087 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | FOXO3 NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 NUP153 | 3.89e-03 | 789 | 89 | 12 | M1060 |
| Pathway | PID_SMAD2_3PATHWAY | 4.47e-03 | 16 | 89 | 2 | M228 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C NUP54 POM121 NUP210 POM121B NUP153 | 1.21e-20 | 38 | 131 | 12 | 12791264 |
| Pubmed | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NUP54 POM121 NUP210 NUP153 | 2.04e-18 | 26 | 131 | 10 | 12228227 | |
| Pubmed | 2.24e-16 | 25 | 131 | 9 | 10601273 | ||
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 1.54e-15 | 30 | 131 | 9 | 24315095 | |
| Pubmed | 1.54e-15 | 30 | 131 | 9 | 27016207 | ||
| Pubmed | 5.74e-14 | 15 | 131 | 7 | 14697343 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NUP54 POM121 MCM3AP NUP153 | 3.59e-13 | 77 | 131 | 10 | 24927568 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NUP50 ZNF609 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CIC NUP54 ARNT RBM12 POM121 OCIAD1 MCM3AP NUP210 NUP153 | 1.83e-12 | 457 | 131 | 17 | 32344865 |
| Pubmed | 2.27e-12 | 40 | 131 | 8 | 37516964 | ||
| Pubmed | HIVEP2 PAK5 NUP98 NUP214 MUC12 NUP42 NUP58 POM121C CIC NUP54 POM121 SYNJ2 MCM3AP NAV2 NUP153 CAP2 | 5.25e-11 | 486 | 131 | 16 | 20936779 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 SYNRG HIVEP2 BCAS3 PAK5 MPDZ NUP62 NSMCE2 CDC14A CIC ARFGEF3 SYNJ2 RPTOR TESK2 SVIL NAV2 SRPK3 NR3C2 PARD3 CAMSAP2 | 8.98e-11 | 861 | 131 | 20 | 36931259 |
| Pubmed | 1.37e-09 | 14 | 131 | 5 | 11073998 | ||
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 11266456 | ||
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 11238447 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF609 HIVEP2 NUP98 PROSER1 NUP214 NUP58 POM121C TFDP1 NUP54 ARNT MCM3AP BAHCC1 | 1.00e-08 | 351 | 131 | 12 | 38297188 |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 1.33e-08 | 8 | 131 | 4 | 31375530 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.34e-08 | 123 | 131 | 8 | 26912792 | |
| Pubmed | 2.39e-08 | 9 | 131 | 4 | 9114010 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.00e-08 | 180 | 131 | 9 | 35198878 | |
| Pubmed | 3.97e-08 | 10 | 131 | 4 | 19581287 | ||
| Pubmed | Interactions and three-dimensional localization of a group of nuclear pore complex proteins. | 5.22e-08 | 3 | 131 | 3 | 8045926 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 5.22e-08 | 3 | 131 | 3 | 30802453 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 35507432 | ||
| Pubmed | Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. | 5.22e-08 | 3 | 131 | 3 | 24943837 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 9847314 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 5.22e-08 | 3 | 131 | 3 | 21327100 | |
| Pubmed | NUP50 SMCHD1 NUP98 NUP62 NUP214 NUP58 POM121C NUP54 MCM3AP SVIL NUP153 | 5.83e-08 | 332 | 131 | 11 | 25693804 | |
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.79e-07 | 34 | 131 | 5 | 18539113 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | FLT1 SMCHD1 MUC16 XPNPEP2 POM121C CIC PDLIM5 ARFGEF3 NFATC2 NAV2 MUC3A UNC80 MAST3 | 1.86e-07 | 552 | 131 | 13 | 10737800 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 SYNRG HIVEP2 BCAS3 WWP1 NUP214 POM121C TNFRSF21 CIC EPS15L1 TRAPPC12 RPTOR MCM3AP NAV2 MLLT6 DOT1L HTT BAHCC1 | 1.91e-07 | 1105 | 131 | 18 | 35748872 |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 2.08e-07 | 4 | 131 | 3 | 17900573 | |
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 10546895 | ||
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 24739174 | ||
| Pubmed | Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence. | 2.08e-07 | 4 | 131 | 3 | 30543681 | |
| Pubmed | 4.40e-07 | 17 | 131 | 4 | 10668806 | ||
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 16730000 | ||
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 19828735 | ||
| Pubmed | Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins. | 5.19e-07 | 5 | 131 | 3 | 23840580 | |
| Pubmed | The nuclear pore complex: from molecular architecture to functional dynamics. | 5.19e-07 | 5 | 131 | 3 | 10395558 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.65e-07 | 18 | 131 | 4 | 18834073 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP3 ZNF609 TRO NUP98 NUP214 POM121C CIC POM121 NFE2L1 MLLT6 NUP153 | 7.63e-07 | 430 | 131 | 11 | 35044719 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 ZNF609 HIVEP2 BCAS3 WWP1 NSMCE2 ADARB1 MAP3K12 ARFGEF3 EPS15L1 SYNJ2 NFIX RPTOR NUP210 TSPAN4 LZTS2 PARD3 CAP2 HTT NPAS2 | 7.99e-07 | 1489 | 131 | 20 | 28611215 |
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 8707840 | ||
| Pubmed | Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex. | 1.81e-06 | 7 | 131 | 3 | 12802065 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 SOX9 SP3 HIVEP2 FOXI3 CIC TFDP1 ARNT NFATC2 HEY1 NFE2L1 NFIX NR3C2 PROX1 NPAS2 | 1.82e-06 | 908 | 131 | 15 | 19274049 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 SYNRG SMCHD1 NUP98 TACC2 NUP62 NUP214 POM121C CIC PDLIM5 EPS15L1 RBM12 CAMSAP2 RSBN1L NUP153 | 2.57e-06 | 934 | 131 | 15 | 33916271 |
| Pubmed | Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. | 2.88e-06 | 8 | 131 | 3 | 26510501 | |
| Pubmed | SOX9 SP3 HIVEP2 TACC2 CIC PDLIM5 TFDP1 ARNT NFATC2 HEY1 NFE2L1 NR3C2 PROX1 | 3.02e-06 | 709 | 131 | 13 | 22988430 | |
| Pubmed | ZNF609 TRO WWP1 RUNX1T1 PREPL CIC PDLIM5 POM121 NYNRIN MLLT6 LZTS2 CAMSAP2 | 3.51e-06 | 608 | 131 | 12 | 16713569 | |
| Pubmed | Cellular cofactors of lentiviral integrase: from target validation to drug discovery. | 4.31e-06 | 9 | 131 | 3 | 22928108 | |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 18596238 | ||
| Pubmed | Molecular cloning and functional characterization of mouse Nxf family gene products. | 6.15e-06 | 10 | 131 | 3 | 15820316 | |
| Pubmed | NUP98 NUP62 NUP214 NUP42 NSMCE2 POM121C NUP54 EPS15L1 RBM12 POM121 HEY1 MCM3AP NUP210 BCL10 RSBN1L | 6.37e-06 | 1007 | 131 | 15 | 34597346 | |
| Pubmed | 6.86e-06 | 121 | 131 | 6 | 22412018 | ||
| Pubmed | 7.18e-06 | 347 | 131 | 9 | 17114649 | ||
| Pubmed | 7.46e-06 | 263 | 131 | 8 | 34702444 | ||
| Pubmed | SYNRG SMCHD1 MPDZ AP3B1 PDLIM5 EPS15L1 LZTS2 DOT1L PARD3 RSBN1L HTT | 7.91e-06 | 549 | 131 | 11 | 38280479 | |
| Pubmed | 8.43e-06 | 11 | 131 | 3 | 23652018 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 25410863 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 1.41e-05 | 2 | 131 | 2 | 27335120 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8812470 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 25919862 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 22558357 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 22777888 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 34886853 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 34665260 | ||
| Pubmed | In vivo intra-articular contrast enhanced μCT imaging of mouse knee cartilage. | 1.41e-05 | 2 | 131 | 2 | 36436817 | |
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 1.41e-05 | 2 | 131 | 2 | 38069401 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 22474286 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 1.41e-05 | 2 | 131 | 2 | 20805576 | |
| Pubmed | Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. | 1.41e-05 | 2 | 131 | 2 | 12163599 | |
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 1.41e-05 | 2 | 131 | 2 | 15044642 | |
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 1.41e-05 | 2 | 131 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 1.41e-05 | 2 | 131 | 2 | 18648499 | |
| Pubmed | Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells. | 1.41e-05 | 2 | 131 | 2 | 16702234 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 1.41e-05 | 2 | 131 | 2 | 8544406 | |
| Pubmed | The Role of Dot1l in Prenatal and Postnatal Murine Chondrocytes and Trabecular Bone. | 1.41e-05 | 2 | 131 | 2 | 32083237 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 14718558 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24418548 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 1.41e-05 | 2 | 131 | 2 | 9916798 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 9916791 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 7531196 | ||
| Pubmed | Dynamic properties of nuclear pore complex proteins in gp210 deficient cells. | 1.41e-05 | 2 | 131 | 2 | 15304359 | |
| Pubmed | The Nup153-Nup50 protein interface and its role in nuclear import. | 1.41e-05 | 2 | 131 | 2 | 23007389 | |
| Pubmed | Acetylation reduces SOX9 nuclear entry and ACAN gene transactivation in human chondrocytes. | 1.41e-05 | 2 | 131 | 2 | 26910618 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 14597763 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23840004 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 32268790 | ||
| Pubmed | Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells. | 1.41e-05 | 2 | 131 | 2 | 31312024 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8589458 | ||
| Pubmed | Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. | 1.41e-05 | 2 | 131 | 2 | 23523133 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 11014860 | ||
| Pubmed | 1.45e-05 | 13 | 131 | 3 | 27160681 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG TACC2 NUP42 NUP58 CIC ARFGEF3 ARNT RPTOR MCM3AP LZTS2 DOT1L | 1.50e-05 | 588 | 131 | 11 | 38580884 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | NUP50 SMCHD1 NUP98 MPDZ NUP214 NHLRC2 EYA2 AP3B1 DNAJC6 CDC14A PREPL NUP210 LZTS2 NUP153 | 1.96e-05 | 974 | 131 | 14 | 28675297 |
| Pubmed | ZNF609 MPDZ NUP214 NHLRC2 PDLIM5 OCIAD1 SYNJ2 TRAPPC12 PROSER3 LRCH4 ANAPC16 RSBN1L | 2.27e-05 | 733 | 131 | 12 | 34672954 | |
| Pubmed | SOX9 ZNF609 SMCHD1 NUP98 PROSER1 NUP62 NUP214 POM121C CIC TFDP1 NUP54 ARNT RBM12 NFIX SVIL MLLT6 DOT1L | 2.76e-05 | 1429 | 131 | 17 | 35140242 | |
| Pubmed | EMC3 Is Essential for Retinal Organization and Neurogenesis During Mouse Retinal Development. | 2.82e-05 | 16 | 131 | 3 | 33605987 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | NUP50 ZNF609 NUP98 NUP62 NUP214 NUP58 AP3B1 NUP54 OCIAD1 PROSER3 NUP210 NUP153 | 2.98e-05 | 754 | 131 | 12 | 33060197 |
| Interaction | NUP35 interactions | NUP50 ZNF609 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CIC NUP54 ARNT RBM12 POM121 OCIAD1 MCM3AP NUP210 NUP153 | 1.13e-09 | 424 | 125 | 17 | int:NUP35 |
| Interaction | GLE1 interactions | NUP98 NUP62 NUP214 NUP42 NUP58 POM121C ADARB1 NUP54 OCIAD1 CPEB4 NUP153 | 2.41e-09 | 150 | 125 | 11 | int:GLE1 |
| Interaction | NUP155 interactions | NUP50 FLT1 NUP98 TACC2 NUP62 NUP214 NUP42 NUP58 POM121C CIC NUP54 POM121 OCIAD1 MCM3AP NUP210 EIF2AK3 NUP153 | 6.59e-09 | 477 | 125 | 17 | int:NUP155 |
| Interaction | KPNB1 interactions | SOX9 NUP50 NUP98 NUP62 NUP214 NHLRC2 NUP42 RUNX1T1 POM121C CIC NUP54 POM121 NFATC2 RPTOR NUP210 DOT1L NUP153 HTT | 7.24e-09 | 544 | 125 | 18 | int:KPNB1 |
| Interaction | NUP153 interactions | NUP50 NUP98 NUP62 NUP214 NUP42 POM121C ADARB1 NUP54 POM121 NUP210 DOT1L NUP153 | 1.03e-08 | 216 | 125 | 12 | int:NUP153 |
| Interaction | NUP107 interactions | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 POM121C CIC NUP54 TRAPPC12 NUP210 NUP153 | 1.33e-08 | 221 | 125 | 12 | int:NUP107 |
| Interaction | MAPRE1 interactions | NUP50 NUP98 TACC2 NUP62 NUP214 NUP42 NUP58 DNAJC6 FCHO1 NUP54 SYNJ2 SVIL NUP210 NAV2 POM121B CAMSAP2 NUP153 | 1.98e-08 | 514 | 125 | 17 | int:MAPRE1 |
| Interaction | SEH1L interactions | NUP98 NUP62 NUP214 NUP42 POM121C TRAPPC12 NUP210 DOT1L DNAJB2 NUP153 | 5.40e-08 | 158 | 125 | 10 | int:SEH1L |
| Interaction | RANBP1 interactions | NUP50 NUP98 NUP62 NUP214 NUP42 NUP58 NUP54 ARNT NUP210 NUP153 HTT | 8.35e-08 | 211 | 125 | 11 | int:RANBP1 |
| Interaction | TLE3 interactions | SOX9 ZNF609 HIVEP2 PROSER1 EYA2 CIC NUP54 ARNT RBM12 POM121 NFIX MCM3AP MLLT6 DOT1L | 9.15e-08 | 376 | 125 | 14 | int:TLE3 |
| Interaction | DPPA3 interactions | 1.90e-07 | 67 | 125 | 7 | int:DPPA3 | |
| Interaction | APC interactions | NUP98 NUP214 NUP42 NUP58 POM121C NUP54 POM121 HEY1 MCM3AP NAV2 LZTS2 PARD3 NUP153 | 9.19e-07 | 389 | 125 | 13 | int:APC |
| Interaction | NUP58 interactions | 1.69e-06 | 92 | 125 | 7 | int:NUP58 | |
| Interaction | RAE1 interactions | 2.19e-06 | 236 | 125 | 10 | int:RAE1 | |
| Interaction | YWHAG interactions | FOXO3 SYNRG HIVEP2 BCAS3 RIMS3 PAK5 MPDZ NUP62 CDC14A CIC NFATC2 SYNJ2 RPTOR TESK2 SVIL NAV2 SYN2 PPIP5K1 LZTS2 PARD3 CAMSAP2 MAST3 HTT | 2.28e-06 | 1248 | 125 | 23 | int:YWHAG |
| Interaction | NUP214 interactions | 3.60e-06 | 195 | 125 | 9 | int:NUP214 | |
| Interaction | YWHAH interactions | FOXO3 SYNRG HIVEP2 BCAS3 PAK5 MPDZ NUP62 NSMCE2 CDC14A CIC ARFGEF3 SYNJ2 RPTOR TESK2 SVIL NAV2 NR3C2 PARD3 CAMSAP2 MAST3 HTT | 4.02e-06 | 1102 | 125 | 21 | int:YWHAH |
| Interaction | NUP85 interactions | 5.89e-06 | 156 | 125 | 8 | int:NUP85 | |
| Interaction | NUP43 interactions | NUP50 ZNF609 NUP98 MUC19 NUP62 NUP214 NUP42 POM121C TFDP1 NUP54 POM121 TRAPPC12 MCM3AP MLLT6 NUP153 | 7.75e-06 | 625 | 125 | 15 | int:NUP43 |
| Interaction | RAN interactions | NUP50 NUP98 NUP62 NUP214 NHLRC2 NUP42 NUP58 ADARB1 NUP54 RPTOR NUP210 NUP153 HTT | 8.18e-06 | 475 | 125 | 13 | int:RAN |
| Interaction | NUP98 interactions | 9.56e-06 | 220 | 125 | 9 | int:NUP98 | |
| Interaction | SIPA1L1 interactions | 1.31e-05 | 174 | 125 | 8 | int:SIPA1L1 | |
| Interaction | CREBBP interactions | FOXO3 SOX9 SP3 HIVEP2 NUP98 TACC2 TFDP1 ARNT NFATC2 NR3C2 CAMSAP2 HTT PROX1 NPAS2 | 2.13e-05 | 599 | 125 | 14 | int:CREBBP |
| Interaction | YWHAE interactions | FOXO3 SYNRG HIVEP2 RIMS3 PAK5 TACC2 CDC14A CIC NFATC2 SYNJ2 RPTOR TESK2 SVIL NAV2 SYN2 DOT1L PARD3 CAMSAP2 CAP2 MAST3 HTT | 2.90e-05 | 1256 | 125 | 21 | int:YWHAE |
| Interaction | DYRK1A interactions | DCHS2 NUP98 NUP214 AP3B1 CIC PDLIM5 SNED1 POM121 ANAPC16 LZTS2 CAMSAP2 RSBN1L NUP153 | 3.95e-05 | 552 | 125 | 13 | int:DYRK1A |
| Interaction | DTX2 interactions | NUP50 ZNF609 NUP98 NUP42 NUP58 EYA2 POM121C NFIX MCM3AP NUP153 | 4.06e-05 | 330 | 125 | 10 | int:DTX2 |
| Interaction | TRIM66 interactions | 4.25e-05 | 205 | 125 | 8 | int:TRIM66 | |
| Interaction | NXF2 interactions | 5.20e-05 | 65 | 125 | 5 | int:NXF2 | |
| Interaction | VASP interactions | 9.24e-05 | 294 | 125 | 9 | int:VASP | |
| Interaction | PLEKHA7 interactions | 9.89e-05 | 119 | 125 | 6 | int:PLEKHA7 | |
| Interaction | SYNE3 interactions | SYNRG NUP98 PROSER1 NUP62 NUP214 NUP58 POM121C PROSER3 NUP210 LZTS2 EIF2AK3 | 1.02e-04 | 444 | 125 | 11 | int:SYNE3 |
| Interaction | NUTF2 interactions | 1.04e-04 | 120 | 125 | 6 | int:NUTF2 | |
| Interaction | SMAD3 interactions | FOXO3 SOX9 WWP1 NUP214 CIC PDLIM5 HEY1 MCM3AP PARD3 NUP153 PROX1 | 1.08e-04 | 447 | 125 | 11 | int:SMAD3 |
| Interaction | NUP205 interactions | 1.11e-04 | 235 | 125 | 8 | int:NUP205 | |
| Interaction | NUP133 interactions | 1.11e-04 | 175 | 125 | 7 | int:NUP133 | |
| Interaction | CATSPER1 interactions | 1.35e-04 | 126 | 125 | 6 | int:CATSPER1 | |
| Interaction | VIM interactions | BCAS3 NHLRC2 CIC PDLIM5 OCIAD1 KRT75 NFATC2 HEY1 SYNJ2 NFIX RPTOR SVIL CPEB4 LZTS2 HTT | 1.38e-04 | 804 | 125 | 15 | int:VIM |
| Interaction | IFI16 interactions | NUP50 SMCHD1 NUP98 NUP62 NUP214 NUP58 POM121C NUP54 NFATC2 MCM3AP SVIL DOT1L RSBN1L NUP153 | 1.40e-04 | 714 | 125 | 14 | int:IFI16 |
| Interaction | DCLK1 interactions | 1.41e-04 | 127 | 125 | 6 | int:DCLK1 | |
| Interaction | NUP160 interactions | 1.47e-04 | 183 | 125 | 7 | int:NUP160 | |
| Interaction | RFX1 interactions | 1.49e-04 | 81 | 125 | 5 | int:RFX1 | |
| Interaction | TCHP interactions | 1.68e-04 | 131 | 125 | 6 | int:TCHP | |
| Interaction | YWHAB interactions | FOXO3 SYNRG PAK5 CDC14A CIC PDLIM5 NFATC2 SYNJ2 TESK2 SVIL NAV2 SYN2 DOT1L PARD3 CAMSAP2 MAST3 HTT | 1.76e-04 | 1014 | 125 | 17 | int:YWHAB |
| Interaction | HELZ interactions | 2.04e-04 | 257 | 125 | 8 | int:HELZ | |
| Interaction | NUP54 interactions | 2.06e-04 | 136 | 125 | 6 | int:NUP54 | |
| Interaction | ZNF638 interactions | 2.27e-04 | 261 | 125 | 8 | int:ZNF638 | |
| Interaction | RNF166 interactions | 2.57e-04 | 91 | 125 | 5 | int:RNF166 | |
| Interaction | TOP3B interactions | FOXO3 SYNRG HIVEP2 BCAS3 WWP1 NUP214 POM121C TNFRSF21 CDC14A CIC EPS15L1 TRAPPC12 RPTOR MCM3AP SVIL CPEB4 NAV2 MLLT6 DOT1L HTT BAHCC1 | 2.68e-04 | 1470 | 125 | 21 | int:TOP3B |
| Interaction | SOX10 interactions | 2.71e-04 | 92 | 125 | 5 | int:SOX10 | |
| Interaction | NUP93 interactions | 2.78e-04 | 269 | 125 | 8 | int:NUP93 | |
| Interaction | KRT33B interactions | 2.85e-04 | 93 | 125 | 5 | int:KRT33B | |
| Interaction | LIN54 interactions | 2.99e-04 | 94 | 125 | 5 | int:LIN54 | |
| Interaction | TCF12 interactions | 3.24e-04 | 148 | 125 | 6 | int:TCF12 | |
| Interaction | NUP188 interactions | 3.24e-04 | 148 | 125 | 6 | int:NUP188 | |
| Interaction | RNF43 interactions | NUP98 NUP42 POM121C POM121 SVIL CPEB4 LZTS2 PARD3 DNAJB2 NUP153 | 3.33e-04 | 427 | 125 | 10 | int:RNF43 |
| Interaction | NFIC interactions | 3.41e-04 | 210 | 125 | 7 | int:NFIC | |
| Interaction | NR3C1 interactions | SMCHD1 NUP98 MUC16 NUP62 NUP214 CSMD2 AP3B1 POM121C PREPL CIC NUP54 TRAPPC12 SVIL NUP210 NR3C2 NUP153 | 3.47e-04 | 974 | 125 | 16 | int:NR3C1 |
| Interaction | TPR interactions | 3.72e-04 | 281 | 125 | 8 | int:TPR | |
| Interaction | CGN interactions | 3.74e-04 | 152 | 125 | 6 | int:CGN | |
| Interaction | RANBP2 interactions | 4.24e-04 | 361 | 125 | 9 | int:RANBP2 | |
| Interaction | SOX6 interactions | 4.44e-04 | 157 | 125 | 6 | int:SOX6 | |
| Interaction | XPOT interactions | 4.51e-04 | 220 | 125 | 7 | int:XPOT | |
| Interaction | SIM2 interactions | 4.85e-04 | 25 | 125 | 3 | int:SIM2 | |
| Interaction | YWHAZ interactions | FOXO3 SYNRG HIVEP2 RIMS3 PAK5 TACC2 AP3B1 CDC14A CIC NFATC2 RPTOR TESK2 SVIL NAV2 SYN2 PARD3 CAMSAP2 MAST3 HTT | 4.90e-04 | 1319 | 125 | 19 | int:YWHAZ |
| Interaction | HDAC1 interactions | NUP50 SP3 ZNF609 BCAS3 NUP98 NUP214 RUNX1T1 DNAJC6 CIC PDLIM5 TFDP1 NUP54 ARNT NFATC2 NFIX DOT1L BAHCC1 | 4.92e-04 | 1108 | 125 | 17 | int:HDAC1 |
| Interaction | ETV6 interactions | 4.99e-04 | 105 | 125 | 5 | int:ETV6 | |
| Cytoband | 7q22 | 1.78e-04 | 38 | 131 | 3 | 7q22 | |
| Cytoband | 7q11.23 | 1.79e-04 | 97 | 131 | 4 | 7q11.23 | |
| Cytoband | 17q23 | 3.58e-04 | 10 | 131 | 2 | 17q23 | |
| Cytoband | 8q21 | 5.23e-04 | 12 | 131 | 2 | 8q21 | |
| Cytoband | 19p13.11 | 1.22e-03 | 73 | 131 | 3 | 19p13.11 | |
| GeneFamily | Nucleoporins | 2.08e-14 | 32 | 86 | 9 | 1051 | |
| GeneFamily | CD molecules|Mucins | 2.68e-06 | 21 | 86 | 4 | 648 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.56e-04 | 57 | 86 | 4 | 1179 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 7.88e-04 | 9 | 86 | 2 | 755 | |
| GeneFamily | Chloride voltage-gated channels | 9.82e-04 | 10 | 86 | 2 | 302 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 SOX9 SP3 HIVEP2 WWP1 SMCHD1 NUP98 AP3B1 ADARB1 PDLIM5 SYNJ2 PARD3 CAMSAP2 NUP153 CAP2 PHLPP2 | 4.96e-06 | 856 | 129 | 16 | M4500 |
| Coexpression | PHONG_TNF_RESPONSE_NOT_VIA_P38 | SOX9 HIVEP2 NUP62 ADARB1 TNFRSF21 PDLIM5 HEY1 NFE2L1 NAV2 PROX1 | 7.62e-06 | 341 | 129 | 10 | M2504 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN | 2.03e-05 | 168 | 129 | 7 | M2991 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-09 | 188 | 131 | 9 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | NUP42 RUNX1T1 CLCNKA CLCNKB SRPK3 TMEM108 UNC80 CCDC158 PROX1 | 7.35e-09 | 197 | 131 | 9 | ff4df77117165b6b25315e29b0722cc136eba607 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-08 | 188 | 131 | 8 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.03e-06 | 179 | 131 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.11e-06 | 181 | 131 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.15e-06 | 182 | 131 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 183 | 131 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 187 | 131 | 7 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.43e-06 | 188 | 131 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.49e-06 | 189 | 131 | 7 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.49e-06 | 189 | 131 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.54e-06 | 190 | 131 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 193 | 131 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-06 | 195 | 131 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-06 | 198 | 131 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-06 | 198 | 131 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 6.90e-06 | 156 | 131 | 6 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 7.97e-06 | 160 | 131 | 6 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.26e-06 | 161 | 131 | 6 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 8.26e-06 | 161 | 131 | 6 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-05 | 168 | 131 | 6 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | Ionocyte-iono-1|World / Class top | 1.09e-05 | 169 | 131 | 6 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 174 | 131 | 6 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-05 | 175 | 131 | 6 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 177 | 131 | 6 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 178 | 131 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-05 | 181 | 131 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.82e-05 | 185 | 131 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-05 | 186 | 131 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.05e-05 | 189 | 131 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 189 | 131 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 189 | 131 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-05 | 189 | 131 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 190 | 131 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 191 | 131 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.18e-05 | 191 | 131 | 6 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 191 | 131 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.24e-05 | 192 | 131 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 192 | 131 | 6 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 192 | 131 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.24e-05 | 192 | 131 | 6 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-05 | 193 | 131 | 6 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-05 | 193 | 131 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 194 | 131 | 6 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 194 | 131 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 194 | 131 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.45e-05 | 195 | 131 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.45e-05 | 195 | 131 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 195 | 131 | 6 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.52e-05 | 196 | 131 | 6 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.59e-05 | 197 | 131 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 197 | 131 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 197 | 131 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 197 | 131 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.59e-05 | 197 | 131 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 198 | 131 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 198 | 131 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 198 | 131 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 198 | 131 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.67e-05 | 198 | 131 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.67e-05 | 198 | 131 | 6 | feac39036b5c0ab97b524cc366286942d136d42f | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 2.74e-05 | 199 | 131 | 6 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 131 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 1d67c5d2c617749b521e70879950dea2c9d076d6 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 131 | 6 | 26c7f2b0afe9e50f2a5c43918ad8e91d7553b72c | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 9.26e-05 | 154 | 131 | 5 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 161 | 131 | 5 | 8de421c61f4d5a6e05fdb20e4d230e2db98ee4d5 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.17e-04 | 162 | 131 | 5 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-04 | 162 | 131 | 5 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-04 | 166 | 131 | 5 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.39e-04 | 168 | 131 | 5 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.39e-04 | 168 | 131 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 168 | 131 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.47e-04 | 170 | 131 | 5 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-04 | 170 | 131 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-04 | 172 | 131 | 5 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 173 | 131 | 5 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 173 | 131 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 173 | 131 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 173 | 131 | 5 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 174 | 131 | 5 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.64e-04 | 174 | 131 | 5 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 175 | 131 | 5 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 175 | 131 | 5 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-04 | 175 | 131 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-04 | 176 | 131 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 177 | 131 | 5 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 177 | 131 | 5 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 177 | 131 | 5 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-04 | 177 | 131 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| Drug | Phe-gly | 7.44e-09 | 73 | 127 | 8 | CID000098207 | |
| Drug | NSC-364372 | FOXO3 SOX9 NUP214 CDC14A EPS15L1 ARNT NFATC2 NFE2L1 ACAN NXF3 LZTS2 DNAJB2 EIF2AK3 HTT | 5.52e-07 | 484 | 127 | 14 | CID000435143 |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A | 1.53e-06 | 195 | 127 | 9 | 3108_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 1.67e-06 | 197 | 127 | 9 | 2674_UP | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.74e-06 | 198 | 127 | 9 | 7372_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.95e-06 | 177 | 127 | 8 | 4652_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.12e-05 | 189 | 127 | 8 | 2672_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.31e-05 | 193 | 127 | 8 | 3773_DN | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.36e-05 | 194 | 127 | 8 | 4531_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.57e-05 | 198 | 127 | 8 | 4096_UP | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.63e-05 | 199 | 127 | 8 | 7355_UP | |
| Drug | thioridazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 1.63e-05 | 199 | 127 | 8 | 422_DN | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.63e-05 | 199 | 127 | 8 | 7336_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.63e-05 | 199 | 127 | 8 | 2830_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.69e-05 | 200 | 127 | 8 | 1829_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 5.00e-05 | 171 | 127 | 7 | 7535_DN | |
| Drug | SAHA; Up 200; 10uM; HL60; HT_HG-U133A | 5.79e-05 | 175 | 127 | 7 | 1161_UP | |
| Drug | 7-chloro-DL-tryptophan | 6.71e-05 | 76 | 127 | 5 | CID000643956 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.91e-05 | 180 | 127 | 7 | 7407_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; HL60; HT_HG-U133A | 7.16e-05 | 181 | 127 | 7 | 1175_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 7.41e-05 | 182 | 127 | 7 | 6879_UP | |
| Drug | SAHA; Up 200; 10uM; HL60; HT_HG-U133A | 8.21e-05 | 185 | 127 | 7 | 2680_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 191 | 127 | 7 | 7417_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; HL60; HT_HG-U133A | 1.04e-04 | 192 | 127 | 7 | 2183_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.07e-04 | 193 | 127 | 7 | 3057_DN | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.07e-04 | 193 | 127 | 7 | 6809_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 127 | 7 | 4284_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 127 | 7 | 4139_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 1156_UP | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 2962_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | 1.18e-04 | 196 | 127 | 7 | 203_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 3327_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 3083_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 1696_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 2225_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 1802_UP | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 7459_UP | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 6137_UP | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 3145_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 3769_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 7275_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 7437_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 7032_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 3424_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 3423_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 5298_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.25e-04 | 198 | 127 | 7 | 440_DN | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 2842_DN | |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | 1.29e-04 | 199 | 127 | 7 | 165_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; HL60; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 2487_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; HL60; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 2349_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | 1.29e-04 | 199 | 127 | 7 | 1568_DN | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; HL60; HG-U133A | 1.29e-04 | 199 | 127 | 7 | 1784_UP | |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 6752_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 1660_DN | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; HL60; HT_HG-U133A | 1.33e-04 | 200 | 127 | 7 | 3020_DN | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 1.33e-04 | 200 | 127 | 7 | 2704_UP | |
| Disease | serum gamma-glutamyl transferase measurement | FOXO3 SP3 POM121C FCHO1 POM121 CLCNKB SYNJ2 SVIL NAV2 SYN2 LZTS2 PARD3 ALPK2 MAST3 BAHCC1 PROX1 | 2.08e-06 | 914 | 127 | 16 | EFO_0004532 |
| Disease | neuroimaging measurement | FOXO3 DCHS2 PAK5 TACC2 RUNX1T1 POM121C SP8 SNAP91 PROSER3 NFIX CPEB4 LRCH4 NAV2 PARD3 EIF2AK3 HTT BAHCC1 | 3.53e-06 | 1069 | 127 | 17 | EFO_0004346 |
| Disease | Bartter disease type 4B | 1.84e-05 | 2 | 127 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 1.84e-05 | 2 | 127 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.84e-05 | 2 | 127 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 1.84e-05 | 2 | 127 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.84e-05 | 2 | 127 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 1.84e-05 | 2 | 127 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 1.84e-05 | 2 | 127 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | body weight | FOXO3 HIVEP2 SMCHD1 PAK5 POM121L2 EYA2 RUNX1T1 AP3B1 POM121C SP8 NFATC2 ACAN CPEB4 TSPAN4 ANAPC16 DOT1L EIF2AK3 | 2.99e-05 | 1261 | 127 | 17 | EFO_0004338 |
| Disease | chronic obstructive pulmonary disease | DCHS2 FLT1 HIVEP2 BCAS3 POM121L2 NUP42 NSMCE2 TESK2 SVIL CPEB4 SYN2 DOT1L | 4.39e-05 | 688 | 127 | 12 | EFO_0000341 |
| Disease | airway responsiveness measurement | 1.48e-04 | 24 | 127 | 3 | EFO_0006897 | |
| Disease | macula measurement | 1.74e-04 | 189 | 127 | 6 | EFO_0008375 | |
| Disease | Bartter syndrome | 2.73e-04 | 6 | 127 | 2 | cv:C0004775 | |
| Disease | platelet component distribution width | FOXO3 CAPN14 HIVEP2 NHLRC2 SYNJ2 NFE2L1 NYNRIN TESK2 SVIL NR3C2 NPAS2 | 4.33e-04 | 755 | 127 | 11 | EFO_0007984 |
| Disease | Autism Spectrum Disorders | 5.06e-04 | 85 | 127 | 4 | C1510586 | |
| Disease | reaction time measurement | 5.74e-04 | 658 | 127 | 10 | EFO_0008393 | |
| Disease | Malignant neoplasm of breast | FLT1 NUP98 TACC2 NUP214 NSMCE2 CIC HEY1 SYNJ2 TRAPPC12 TSPAN4 FCRL5 LZTS2 MAGEC2 | 7.55e-04 | 1074 | 127 | 13 | C0006142 |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 8.09e-04 | 10 | 127 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | bipolar disorder | 9.04e-04 | 577 | 127 | 9 | MONDO_0004985 | |
| Disease | Psychotic Disorders | 9.68e-04 | 101 | 127 | 4 | C0033975 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.03e-03 | 364 | 127 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | visceral adipose tissue measurement | 1.16e-03 | 481 | 127 | 8 | EFO_0004765 | |
| Disease | myopathy (implicated_via_orthology) | 1.17e-03 | 48 | 127 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-03 | 49 | 127 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Dupuytren Contracture | 1.24e-03 | 108 | 127 | 4 | EFO_0004229 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.39e-03 | 13 | 127 | 2 | C0238288 | |
| Disease | peak expiratory flow | 1.45e-03 | 498 | 127 | 8 | EFO_0009718 | |
| Disease | glycodeoxycholate measurement | 1.62e-03 | 14 | 127 | 2 | EFO_0010493 | |
| Disease | growth-regulated alpha protein measurement | 1.73e-03 | 55 | 127 | 3 | EFO_0008146 | |
| Disease | cancer biomarker measurement | 1.86e-03 | 15 | 127 | 2 | EFO_0005127 | |
| Disease | body surface area | 1.90e-03 | 643 | 127 | 9 | EFO_0022196 | |
| Disease | pro-hydroxy-pro measurement | 2.12e-03 | 16 | 127 | 2 | EFO_0021132 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.12e-03 | 125 | 127 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.12e-03 | 125 | 127 | 4 | C1879321 | |
| Disease | FEV/FEC ratio | FOXO3 DCHS2 FLT1 HIVEP2 TCP11 BCAS3 RUNX1T1 NSMCE2 ACAN SVIL CPEB4 NAV2 PARD3 | 2.49e-03 | 1228 | 127 | 13 | EFO_0004713 |
| Disease | fat body mass | 2.53e-03 | 217 | 127 | 5 | EFO_0005409 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.68e-03 | 64 | 127 | 3 | DOID:4947 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | 2.68e-03 | 550 | 127 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Schizophrenia | 2.69e-03 | 18 | 127 | 2 | cv:C0036341 | |
| Disease | hearing loss | 3.05e-03 | 67 | 127 | 3 | EFO_0004238 | |
| Disease | radiation-induced disorder | 3.05e-03 | 67 | 127 | 3 | EFO_0009565 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.19e-03 | 566 | 127 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | triglyceride measurement, body fat percentage | 3.66e-03 | 21 | 127 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Alzheimer disease, age at onset | 3.76e-03 | 343 | 127 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | creatinine measurement | FOXO3 BCAS3 CDC14A PDLIM5 NFE2L1 SVIL SYN2 PARD3 RSBN1L UNC80 CCDC158 | 3.87e-03 | 995 | 127 | 11 | EFO_0004518 |
| Disease | pentachlorophenol measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 4.04e-03 | 74 | 127 | 3 | EFO_0007886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVGSFQTPSSFSSMS | 666 | P27540 | |
| FSSSSVSSKGSDPFG | 711 | Q9UBC2 | |
| QVFSLAGSTFSLPST | 611 | P55198 | |
| GSSPASSFMGSFLTS | 66 | Q9P281 | |
| SNDPSTSASQSFGIT | 1071 | Q9P281 | |
| SSVTGSGFSVSDLAP | 16 | Q96DE5 | |
| GTFSGNQLPSSITSS | 646 | Q7Z408 | |
| TSSSESQFSPLEFSG | 731 | Q9NZJ5 | |
| SPFTGTTTISFSNLG | 681 | Q86TB3 | |
| SSSSKAGFTASPFTN | 501 | Q9UNH5 | |
| NFEAAFGTTPSTSSS | 696 | O60641 | |
| SGSLFATVGSRSSTP | 971 | Q8TEK3 | |
| SNSSGSTSGSIPRNF | 891 | Q9H6U6 | |
| DTSFPATLSSIGSGS | 46 | A8MX76 | |
| STISPSGAFGLFSSD | 26 | O00203 | |
| SSVPLTGFSFSPGNS | 286 | Q9UKX7 | |
| LAPSNSTSLNSTFGS | 396 | Q14494 | |
| TSSASSGQGIFSFRP | 226 | A8MTL3 | |
| NMGASFGSPTFSSTV | 161 | Q9NTZ6 | |
| FGSPTFSSTVPSTAS | 166 | Q9NTZ6 | |
| SFLFRSSSQSGSGPS | 506 | O75427 | |
| QSSGRSGSSLVSPFS | 621 | Q99743 | |
| SSFSSSGGRQSSPLT | 36 | Q96LL4 | |
| SFQFTPSRTAGTSGC | 231 | Q9P286 | |
| AGSQGPLSTTLTFSS | 1756 | Q8TEM1 | |
| GSSSLGFTSSPSPFS | 451 | O14526 | |
| FTRTFIATPGSSSSL | 471 | Q9H4D5 | |
| SSFQSTGFTETPEGS | 2951 | Q8WXI7 | |
| SSGSSASFISDTFSP | 171 | Q13469 | |
| GLFGTSSFSQPATST | 61 | P52948 | |
| SSFSQPATSTSTGFG | 66 | P52948 | |
| FGTSTGTANTLFGTA | 81 | P52948 | |
| LFGTASTGTSLFSSQ | 91 | P52948 | |
| SATGLFSSSTTNSGF | 236 | P52948 | |
| FGTATNTSTGTAFGT | 331 | P52948 | |
| TTFGSSTTSAPSFGT | 371 | P52948 | |
| FPASTSGGQSSPFSS | 386 | A8MTJ6 | |
| SPSFATTGASSANRF | 466 | Q14938 | |
| SPSPISSFFSGSGSK | 121 | Q9Y662 | |
| SPAGINSVSSTTASF | 206 | P08235 | |
| NSVSSTTASFGSFPV | 211 | P08235 | |
| QLFGGPASSSSSSSS | 181 | Q9BRK4 | |
| SPSSFSTSSSLILGG | 51 | Q9UBF1 | |
| GTASLGLFLSSTFPS | 406 | Q8N468 | |
| GFSNGPSSSSSSSLA | 96 | Q06455 | |
| TFSSLTSVGFGNVSP | 621 | Q9NS40 | |
| FSGSGSGTDFTLTIN | 81 | A0A0C4DH24 | |
| SLGSFPVTSASASAG | 1661 | Q5HYC2 | |
| PFSGQQPSAFSASSS | 6 | O60318 | |
| SGKSSGFSQVSSFPA | 46 | O60318 | |
| GFSQVSSFPASSGVS | 51 | O60318 | |
| QTLGFTQTSSVGPFS | 71 | O60318 | |
| SSSVLGNTGFSFKSP | 101 | O60318 | |
| IFGSSNNSFSSFPVS | 241 | O60318 | |
| ASTVSAFSVLSSGPG | 216 | P40123 | |
| SSSTPSVGRVSFSFS | 516 | Q96RD9 | |
| FSGSGSGTDFTLTIN | 81 | A0A0A0MT36 | |
| VAPGSFSTATTSSGA | 7246 | Q7Z5P9 | |
| GTTVAPGSFSTAATT | 7691 | Q7Z5P9 | |
| TGQTTFTSSTATFPE | 596 | Q02505 | |
| TGTGQTTFPSSTATF | 1346 | Q02505 | |
| NVGSASITGFPSLSS | 2721 | Q02505 | |
| SSNSGSTGFISFSGV | 6 | Q96MF7 | |
| TAAATPQVSSSGFSS | 1696 | P35658 | |
| PQVSSSGFSSPAFGT | 1701 | P35658 | |
| SSTPTSTSGSVFGAA | 1761 | P35658 | |
| SSSFSFGQSSPNTGG | 1781 | P35658 | |
| FGSSSNTTSFGTLAS | 2026 | P35658 | |
| QTSFCGFPSFSTSGT | 41 | Q8IUG1 | |
| QTSFCGFPSFSTSGT | 41 | Q9BYS1 | |
| LSTAFSTGTVFSGSF | 891 | A8MYU2 | |
| PSTGRISNSATYSGS | 371 | Q96HC4 | |
| TPATQTTGFTFGTAT | 66 | P37198 | |
| SSTVTSSQGTAPTGF | 126 | P37198 | |
| TTSVAPATTSGGFSF | 146 | P37198 | |
| LSDPSTSTFQGAGTT | 491 | P78563 | |
| VTSSSFTESTFNEPG | 521 | Q8NBF2 | |
| TVDSSGFTSQTPEFS | 1881 | P16112 | |
| STSSGISTSAPAFGF | 276 | O15504 | |
| SSEGTPLAVFASSFS | 2981 | Q6V1P9 | |
| SGFGSTLATSAPATS | 896 | A8CG34 | |
| SSQPAFGGSTAVFSF | 1031 | A8CG34 | |
| VPTATSSSAADFSGF | 491 | A6NF01 | |
| NTSTPTFNIPFGSSA | 526 | A6NF01 | |
| LTPSFGSSFTFGNSA | 571 | A6NF01 | |
| SSQPAFGGSTAVFSF | 636 | A6NF01 | |
| GSSEAFASTSAPFTS | 391 | Q86XN7 | |
| TSTTAGSAFSFSAPT | 31 | Q7Z3B4 | |
| GSAFSFSAPTNTGTT | 36 | Q7Z3B4 | |
| SSVSGQSSFVTSPAA | 136 | Q9NX40 | |
| FGFGINSVSSSSVST | 836 | Q96HA1 | |
| TTSTATAASQPFLFG | 851 | Q96HA1 | |
| FGSTLATSAPATSSQ | 921 | Q96HA1 | |
| SNTSTPTFNIPFGSS | 941 | Q96HA1 | |
| FSQSSGTLASNPATF | 371 | P0CG12 | |
| SGPVTTSKSSSLGSF | 1216 | P42858 | |
| SFSPGAGAFRSVSTS | 156 | P25686 | |
| PEGESSTTPFFSTNS | 156 | O95999 | |
| PSFQSESSTPSTGGF | 1941 | Q5TH69 | |
| GFIGEFQSFSSASSP | 11 | P10643 | |
| LGSFLNTSSASSDPF | 596 | O75061 | |
| SPSFGGFVSTLSEAS | 11 | Q12852 | |
| SSGYGTNTPSSTLSS | 91 | O60307 | |
| SSVASLSAFPFSFGS | 256 | Q9Y5J3 | |
| QPLTSSASSLTGFSN | 156 | Q17RY0 | |
| TSVGQPSTSTFKATG | 691 | Q96PD2 | |
| SNGGSSSSFFVSSIR | 21 | Q5M9N0 | |
| SDFPSSGEGATFTQS | 376 | Q08AD1 | |
| SPVSGSSPFQLTAFS | 991 | Q5VVW2 | |
| GTPATTSAATTGFSL | 96 | Q9BVL2 | |
| GSSSTSGFNFSNPGI | 546 | Q9BVL2 | |
| LSGSSPFSSAFNSLS | 1501 | Q9P2P1 | |
| TSASSTGTQSPEIFG | 91 | Q8TEW0 | |
| FTSADTGNSLSAFPS | 61 | Q96BN6 | |
| FLSYGSSFSTSPTGQ | 116 | O00167 | |
| SGLGSPTSSFNSTVF | 421 | O43524 | |
| PTSSFNSTVFGPSSL | 426 | O43524 | |
| PGFQQASISSSSSSA | 21 | Q6KF10 | |
| RSSFSFSAGTAVPSS | 101 | Q6PCB5 | |
| PSVGSSFFSSLSQAV | 76 | Q92777 | |
| FSPSSLSSLSIAGVG | 1186 | A6NHR9 | |
| TDSGFTFSSPNFATI | 191 | Q9BUD6 | |
| SFSSSTSPSPGTAIF | 216 | O75509 | |
| SPAAESSSTFSFSGR | 221 | O95425 | |
| TVFPQGDFLSTSSAT | 1376 | O15056 | |
| FVLSAGSGSPSATSI | 911 | Q9UMZ2 | |
| STNSNSSDGTFIFPT | 111 | Q9UJD0 | |
| QSPLSATTGFTTSTF | 466 | Q92786 | |
| SSSRTPTANANSFGF | 1131 | Q8IVL1 | |
| FSSGSSVTSPSGTRF | 1551 | Q8IVL1 | |
| TSSFPTSSDGLSPFS | 226 | Q2NL68 | |
| TGSYGISSTAATPAS | 316 | P48436 | |
| TSSGFSGSVENGTFL | 6 | A2A2V5 | |
| ATAVVGFGSSPTSTN | 346 | P29508 | |
| SSSFLFGSSAVALPT | 796 | Q96KW2 | |
| AVAFSPGNLSTSSSA | 751 | Q8N122 | |
| PSSLSDSSSSFGKGF | 16 | Q8IXZ3 | |
| RVTFFGGSSSSPVNT | 156 | Q8TER0 | |
| SGFSGSLFSPASCSI | 351 | Q9UPE1 | |
| SSSFPTSPVNSDFGF | 16 | Q8N365 | |
| SYGPTSSVALGFTSL | 1031 | Q96RK0 | |
| FSSGFSQSITPSSGG | 106 | P51800 | |
| FSSGFSQSITPSSGG | 106 | P51801 | |
| SSFSGSVLFGSPQFV | 341 | Q8WWU5 | |
| FITTAGSTSNGTRFS | 346 | Q14186 | |
| SPTRSTFSFGSFSGL | 486 | Q8N2C7 | |
| GSLSSFTFPLSGSST | 1826 | O75970 | |
| SGLFQRQPSSATFSS | 1126 | Q6ZVD8 | |
| GITFGVAPSTSASFS | 756 | Q12816 | |
| SASFSNTASISFGGT | 766 | Q12816 | |
| GVSSSFSGPLSTSAT | 826 | Q12816 | |
| GVLSTSTSFGSAPTT | 861 | Q12816 | |
| STSFGSAPTTSTVFS | 866 | Q12816 | |
| STVFSSALSTSTGFG | 876 | Q12816 | |
| SASFGSVLNTSTGFG | 976 | Q12816 | |
| PSTSTGFSFGNGLST | 1191 | Q12816 | |
| SNTSTGFTGEPSTST | 1341 | Q12816 | |
| SFTTSAFISVSNPGA | 226 | Q8WVT3 | |
| AAGGAFTSTPVSLST | 501 | Q02447 | |
| FQTATFTAASPGSSS | 671 | O15014 | |
| FTAASPGSSSGLTAT | 676 | O15014 | |
| GFSQPSLTTLTAFSA | 546 | Q4J6C6 | |
| SSFSFSSGIDQSPGM | 186 | O95359 | |
| STSSAFPIGSSGFSL | 151 | P49790 | |
| SSFKFGVSSSSSGPS | 901 | P49790 | |
| SSGPSQTLTSTGNFK | 911 | P49790 | |
| ATTSSTGTAVTPFVF | 1261 | P49790 | |
| SNNTTTSGFGFGATT | 1281 | P49790 | |
| FGATTTSSSAGSSFV | 1291 | P49790 | |
| FGSISSSTALFPTGS | 1341 | P49790 | |
| SAFGSGTTPNSSSAF | 1381 | P49790 | |
| GTTPNSSSAFQFGSS | 1386 | P49790 | |
| ATQGSFATLSSSFPS | 36 | O14817 | |
| SSGPSFETISASGLN | 411 | O43895 | |
| SSSFAPTDNASVTGT | 246 | Q9H0M0 | |
| STPATFSTSGIGLQT | 551 | Q96S53 | |
| LTGNSGFTYSTPAFS | 1176 | P17948 | |
| DGLQSGSSSFSSLSP | 1506 | P31629 | |
| SSPTTVDGNSQFGFS | 1181 | Q6PFW1 | |
| GTSRPLSTSSGVFTA | 341 | Q6UXF1 | |
| LSTSSGVFTAATGPT | 346 | Q6UXF1 | |
| GFSTTSAITPAAGRS | 16 | O95678 | |
| NAGVGFSITSSTFSS | 491 | Q8N8K9 | |
| PGSTTALSFGQESTT | 1066 | Q9UKN1 | |
| SFGQESTTFHSSPGS | 2156 | Q9UKN1 | |
| ASSTSPGLQGESTAF | 2206 | Q9UKN1 | |
| GSTTTPGLSEASTTF | 2316 | Q9UKN1 | |
| FGQESTTFHSSPGST | 2631 | Q9UKN1 | |
| GSTTASSLGPESTTF | 3321 | Q9UKN1 | |
| PGSTTALSFGQESTT | 3706 | Q9UKN1 |